Endocrine, metabolic & immune disorders drug targets
Genetic Pathogenesis and Treatment of Forkhead Box A2 Hyperinsulinemia.
Yangmingyue Ji, Congli Chen, Yanmei Sang
Published: 202510.2174/0118715303396043250929055236
Abstract
Congenital hyperinsulinemia (CHI) is a clinically heterogeneous disorder that is the leading cause of persistent and recurrent hypoglycemia in infancy and childhood. There are 39 pathogenic genes associated with CHI. The forkhead box A2 (FOXA2) gene…
Preview only. Read the full abstract at the source